Polyak, A.; Bankstahl, J.P.; Besecke, K.F.W.; Hozsa, C.; Triebert, W.; Pannem, R.R.; Manstein, F.; Borcholte, T.; Furch, M.; Zweigerdt, R.;
et al. Simplified 89Zr-Labeling Protocol of Oxine (8-Hydroxyquinoline) Enabling Prolonged Tracking of Liposome-Based Nanomedicines and Cells. Pharmaceutics 2021, 13, 1097.
https://doi.org/10.3390/pharmaceutics13071097
AMA Style
Polyak A, Bankstahl JP, Besecke KFW, Hozsa C, Triebert W, Pannem RR, Manstein F, Borcholte T, Furch M, Zweigerdt R,
et al. Simplified 89Zr-Labeling Protocol of Oxine (8-Hydroxyquinoline) Enabling Prolonged Tracking of Liposome-Based Nanomedicines and Cells. Pharmaceutics. 2021; 13(7):1097.
https://doi.org/10.3390/pharmaceutics13071097
Chicago/Turabian Style
Polyak, Andras, Jens P. Bankstahl, Karen F. W. Besecke, Constantin Hozsa, Wiebke Triebert, Rajeswara Rao Pannem, Felix Manstein, Thomas Borcholte, Marcus Furch, Robert Zweigerdt,
and et al. 2021. "Simplified 89Zr-Labeling Protocol of Oxine (8-Hydroxyquinoline) Enabling Prolonged Tracking of Liposome-Based Nanomedicines and Cells" Pharmaceutics 13, no. 7: 1097.
https://doi.org/10.3390/pharmaceutics13071097
APA Style
Polyak, A., Bankstahl, J. P., Besecke, K. F. W., Hozsa, C., Triebert, W., Pannem, R. R., Manstein, F., Borcholte, T., Furch, M., Zweigerdt, R., Gieseler, R. K., Bengel, F. M., & Ross, T. L.
(2021). Simplified 89Zr-Labeling Protocol of Oxine (8-Hydroxyquinoline) Enabling Prolonged Tracking of Liposome-Based Nanomedicines and Cells. Pharmaceutics, 13(7), 1097.
https://doi.org/10.3390/pharmaceutics13071097